InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| DMXAA | STING is an intrinsic checkpoint inhibitor that restrains the T H 17 cell pat... | 2022 | Cell Rep. | Damasceno L.E.A. et al. | DOI: 10.1016/j.celrep.2022.110838 |
| ADU-S100 | STING is an intrinsic checkpoint inhibitor that restrains the T H 17 cell pat... | 2022 | Cell Rep. | Damasceno L.E.A. et al. | DOI: 10.1016/j.celrep.2022.110838 |
| IL-4 & IL-13 Reporter HEK 293 Cells | Lagerstroemia indica extract regulates human hair dermal papilla cell growth ... | 2022 | J Cosmet Dermatol. | Kim B.H. et al. | DOI: 10.1111/jocd.15081 |
| LyoVec™ | Competition for dominance within replicating quasispecies during prolonged SA... | 2022 | Virus Evol. | Caccuri F. et al. | DOI: 10.1093/ve/veac042 |
| 3p-hpRNA - RIG-I agonist | Competition for dominance within replicating quasispecies during prolonged SA... | 2022 | Virus Evol. | Caccuri F. et al. | DOI: 10.1093/ve/veac042 |
| R848 (Resiquimod) | Competition for dominance within replicating quasispecies during prolonged SA... | 2022 | Virus Evol. | Caccuri F. et al. | DOI: 10.1093/ve/veac042 |
| Poly(I:C) HMW | Competition for dominance within replicating quasispecies during prolonged SA... | 2022 | Virus Evol. | Caccuri F. et al. | DOI: 10.1093/ve/veac042 |
| ODN 4084-F | Bone marrow-derived macrophages from a murine model of Sjögren's syndrome dem... | 2022 | Sci Rep. | Witas R. et al. | DOI: 10.1038/s41598-022-12608-4 |
| Imiquimod VacciGrade™ (R837) | Bone marrow-derived macrophages from a murine model of Sjögren's syndrome dem... | 2022 | Sci Rep. | Witas R. et al. | DOI: 10.1038/s41598-022-12608-4 |
| OxPAPC | Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage ... | 2022 | Cell Mol Life Sci. | Umar S. et al. | DOI: 10.1007/s00018-022-04329-8 |
| ODN TTAGGG (A151) | Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage ... | 2022 | Cell Mol Life Sci. | Umar S. et al. | DOI: 10.1007/s00018-022-04329-8 |
| Human TLR1-9 Agonist kit | The impact of short-term confinement on human innate immunity. | 2022 | Sci Rep. | Ponomarev S.A. et al. | DOI: 10.1038/s41598-022-12380-5 |
| QUANTI-Luc™: Luciferase Detection Reagent | SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly i... | 2022 | Sci Rep | Song C. et al. | DOI: 10.1038/s41598-022-12449-1 |
| THP1-Dual™ Cells | SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly i... | 2022 | Sci Rep | Song C. et al. | DOI: 10.1038/s41598-022-12449-1 |
| THP1-Dual™ KO-STING Cells | SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly i... | 2022 | Sci Rep | Song C. et al. | DOI: 10.1038/s41598-022-12449-1 |
| MRT67307 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| RU.521 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| STING inhibitor | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| BX795 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| Pam3CSK4 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |